Who has invested in Elevara Medicine?

Forbion, Sofinnova Partners, Monograph Capital, Weatherden are named among the investors backing Elevara Medicine.

Elevara Medicine Funding: $70M Raised, Series A (2025)

Elevara Medicine funding overview

Elevara Medicine is based in London, UK. Elevara Medicine has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2025. The round record for Elevara Medicine runs through 2025; nothing later has been disclosed. Investors on record include Forbion, Sofinnova Partners, Monograph Capital, Weatherden. 4 distinct backers are named across the disclosed rounds.

Elevara Medicine at a glance

Total raised: $70M
Latest round: Series A
Latest round date: October 2025
Headquarters: London, UK
Notable investors: Forbion, Sofinnova Partners, Monograph Capital, Weatherden

Frequently asked about Elevara Medicine funding

How much has Elevara Medicine raised?: Elevara Medicine has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Elevara Medicine?: Forbion, Sofinnova Partners, Monograph Capital, Weatherden are named among the investors backing Elevara Medicine.
What was the latest Elevara Medicine funding round?: The most recent disclosed round is a Series A, announced in October 2025.
Where is Elevara Medicine based?: Elevara Medicine is based in London, UK.
When did Elevara Medicine last raise?: The last disclosed Elevara Medicine round closed in October 2025 at Series A.

We update the Elevara Medicine record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in London and their backers are listed below.

Elevara Medicine Funding: $70M Raised, Series A (2025)

Elevara Medicine funding overview

Elevara Medicine at a glance

Frequently asked about Elevara Medicine funding

Companies related to Elevara Medicine (36)

Browse related funding lists (8)